pubmed-article:8648206 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0021051 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0305065 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0032594 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C2754943 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0021006 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0546816 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C0205151 | lld:lifeskim |
pubmed-article:8648206 | lifeskim:mentions | umls-concept:C2713304 | lld:lifeskim |
pubmed-article:8648206 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:8648206 | pubmed:dateCreated | 1996-7-25 | lld:pubmed |
pubmed-article:8648206 | pubmed:abstractText | Human immunodeficiency virus (HIV)-infected persons are less likely than are noninfected persons to respond to vaccination with pneumococcal polysaccharides (PPS). Among those who respond, however, similar IgG levels may be achieved. HIV-infected men immunized with pneumococcal vaccine were classified as high- or low-level responders (IgG > or = 1 microgram/mL for > or = 3 of 5 PPS [high] or for < or = 1 PPS [low]). One and 2 years after immunization, geometric mean IgG levels and the percentages of subjects with IgG levels > or = 1 microgram/mL were similar for HIV-infected and for healthy high-level responders (controls) for all PPS except for serotype 8. Among HIV-infected low-level responders, revaccination with a double dose of pneumococcal vaccine did not stimulate IgG responses. Responsiveness of HIV-infected white patients was significantly associated with the Km(1)- negative allotype. These findings support current general recommended guidelines for administering pneumococcal vaccine to HIV-infected persons. Nonresponders will not benefit from revaccination. | lld:pubmed |
pubmed-article:8648206 | pubmed:language | eng | lld:pubmed |
pubmed-article:8648206 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8648206 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8648206 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8648206 | pubmed:month | Jun | lld:pubmed |
pubmed-article:8648206 | pubmed:issn | 0022-1899 | lld:pubmed |
pubmed-article:8648206 | pubmed:author | pubmed-author:MusherD MDM | lld:pubmed |
pubmed-article:8648206 | pubmed:author | pubmed-author:PandeyJ PJP | lld:pubmed |
pubmed-article:8648206 | pubmed:author | pubmed-author:GumpD WDW | lld:pubmed |
pubmed-article:8648206 | pubmed:author | pubmed-author:Rodriguez-Bar... | lld:pubmed |
pubmed-article:8648206 | pubmed:author | pubmed-author:GrooverJ EJE | lld:pubmed |
pubmed-article:8648206 | pubmed:author | pubmed-author:LahartC JCJ | lld:pubmed |
pubmed-article:8648206 | pubmed:author | pubmed-author:LackeC ECE | lld:pubmed |
pubmed-article:8648206 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8648206 | pubmed:volume | 173 | lld:pubmed |
pubmed-article:8648206 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8648206 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8648206 | pubmed:pagination | 1347-53 | lld:pubmed |
pubmed-article:8648206 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:meshHeading | pubmed-meshheading:8648206-... | lld:pubmed |
pubmed-article:8648206 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8648206 | pubmed:articleTitle | IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. | lld:pubmed |
pubmed-article:8648206 | pubmed:affiliation | Medical Service, VA Medical Center, Houston, TX 77030, USA. | lld:pubmed |
pubmed-article:8648206 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8648206 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8648206 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8648206 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8648206 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8648206 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8648206 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8648206 | lld:pubmed |